Temporal trends in severe malaria in Chittagong, Bangladesh
- Richard James Maude1, 2, 3Email author,
- Mahtab Uddin Hasan4,
- Md Amir Hossain4,
- Abdullah Abu Sayeed4,
- Sanjib Kanti Paul4,
- Waliur Rahman4,
- Rapeephan Rattanawongnara Maude1,
- Nidhi Vaid5,
- Aniruddha Ghose4,
- Robed Amin6,
- Rasheda Samad4,
- Emran Bin Yunus7, 8,
- M Ridwanur Rahman9,
- Abdul M Bangali10,
- M Gofranul Hoque4,
- Nicholas PJ Day1, 2,
- Nicholas J White1, 2,
- Lisa J White1, 2,
- Arjen M Dondorp1, 2 and
- M Abul Faiz1, 7, 8
© Maude et al.; licensee BioMed Central Ltd. 2012
Received: 8 May 2012
Accepted: 28 August 2012
Published: 12 September 2012
Epidemiological data on malaria in Bangladesh are sparse, particularly on severe and fatal malaria. This hampers the allocation of healthcare provision in this resource-poor setting. Over 85% of the estimated 150,000-250,000 annual malaria cases in Bangladesh occur in Chittagong Division with 80% in the Chittagong Hill Tracts (CHT). Chittagong Medical College Hospital (CMCH) is the major tertiary referral hospital for severe malaria in Chittagong Division.
Malaria screening data from 22,785 inpatients in CMCH from 1999–2011 were analysed to investigate the patterns of referral, temporal trends and geographical distribution of severe malaria in Chittagong Division, Bangladesh.
From 1999 till 2011, 2,394 malaria cases were admitted, of which 96% harboured Plasmodium falciparum and 4% Plasmodium vivax. Infection was commonest in males (67%) between 15 and 34 years of age. Seasonality of malaria incidence was marked with a single peak in P. falciparum transmission from June to August coinciding with peak rainfall, whereas P. vivax showed an additional peak in February-March possibly representing relapse infections. Since 2007 there has been a substantial decrease in the absolute number of admitted malaria cases. Case fatality in severe malaria was 18% from 2008–2011, remaining steady during this period.
A travel history obtained in 226 malaria patients revealed only 33% had been to the CHT in the preceding three weeks. Of all admitted malaria patients, only 9% lived in the CHT, and none in the more remote malaria endemic regions near the Indian border.
The overall decline in admitted malaria cases to CMCH suggests recent control measures are successful. However, there are no reliable data on the incidence of severe malaria in the CHT, the most endemic area of Bangladesh, and most of these patients do not reach tertiary health facilities. Improvement of early treatment and simple supportive care for severe malaria in remote areas and implementation of a referral system for cases requiring additional supportive care could be important contributors to further reducing malaria-attributable disease and death in Bangladesh.
Over a million suspected cases of malaria are reported annually to the World Health Organization (WHO) in Bangladesh, although the number of confirmed cases is only 60,000, and estimates of the true incidence vary widely[1–3]. Cases from most medical college hospitals, specialized hospitals, NGO hospitals and private clinics and hospitals are not included and the true number is estimated to be three times higher[1, 4]. Most malaria cases in Bangladesh did not have a confirmatory blood test until recently and clinical diagnosis of malaria is known to be unreliable[5, 6]. Since 2000, no clear decrease in the overall annual number of cases has been documented, but this could be related to counting methods[2, 3, 5, 7]. From 2006–2008, the number of people tested for malaria more than doubled, but despite this, in 2008 only a third of 1.3 million reported suspected cases had a blood test for malaria (microscopy or rapid diagnostic test), one fifth of which (85,000) were positive. The true incidence of malaria is thus probably in the range of 150,000-250,000 cases per year[1, 3, 4].
It is likely that an increase in the efficiency of diagnosis and reporting has masked a decline in incidence. Access to artemisinin combination therapy (ACT) has doubled since 2005 and annual reported numbers of confirmed deaths from malaria has decreased 10-fold since 2005 to 47 in 2009. It should be noted that these figures do not include deaths in many hospitals and private facilities or those that do not reach health care and the true figure is likely to be much larger.
Accurate figures for numbers of cases of severe malaria in Bangladesh are not readily available. An exception is a WHO report from 2006 reporting 513 case fatalities out of a total of 51,705 confirmed falciparum malaria cases, of which 3,539 were severe. It was estimated that there were 2,200-12,000 actual fatal cases in that year and 1,108,000-6,677,000 total cases of all species malaria in Bangladesh in 2006. A later WHO report stated there were 1,320,581 reported cases in 2006. With a case fatality rate in severe malaria of 15-20%, the number of fatal cases suggests a total of 11,000-80,000 severe malaria cases in that year. More recently, a total number of 3591 cases of severe malaria cases were counted between July 2008 and May 2009. There are no published data on long-term trends and very little on the geographical distribution of severe malaria in Bangladesh.
Mortality from severe malaria can be greatly reduced by intravenous anti-malarials (particularly artesunate) and high quality supportive care. In Bangladesh, intravenous anti-malarials are widely available in local hospitals but access to advanced supportive care (e.g. blood transfusion, mechanical ventilation and renal dialysis) is much more limited. Recommended practice in Bangladesh is for all severe cases of malaria to be treated in hospital. Numbers of malaria admissions may thus be a useful surrogate in the absence of reliable data on severe disease. Numbers of patients with malaria admitted to hospital in Bangladesh have been published since 2007. There were 5678 such admissions reported in 2007, 3042 in 2008 and 3287 in 2009. This is around half of the lowest estimate for the annual number of severe cases (above) and very few of these would have had access to tertiary level care. There is thus likely to be a large burden of patients who do not reach hospital, representing potentially preventable mortality. In order to improve care for people with severe malaria in Bangladesh it is important to describe this population in more detail.
A study was undertaken using routinely collected malaria screening data from the past 13 years from Chittagong Medical College Hospital (CMCH), Bangladesh to investigate the patterns of referral of patients, temporal trends and geographical distribution of severe malaria in Chittagong Division.
Place and period of study
The study was conducted at CMCH, Chittagong, Bangladesh from January 1999 to December 2011. CMCH is a government-run 1000-bed teaching hospital and the main tertiary referral hospital for severe malaria in Chittagong Division. CMCH receives referrals from throughout southeast Bangladesh, particularly those severe cases who require more intensive management as it is the only government hospital in the south of Chittagong Division with facilities for intensive care and haemodialysis. Its patients are mostly in the lower income range. There is a high quality malaria diagnostic service on-site with a well-developed recording system for malaria screening results. As the malaria laboratory is readily accessible, being located next to the medical wards, and the test is free to the patients, most if not all patients with suspected malaria undergo testing through this facility. The vast majority of malaria patients admitted to CMCH have severe disease. The results thus provide a representative picture of severe malaria cases admitted to CMCH over time. Assuming referral patterns from outlying clinics and hospitals to CMCH have not changed significantly in this period, they may also give an indication of long-term trends of severe malaria across Chittagong Division.
Results of all screening of inpatients for malaria by the CMCH malaria diagnostic laboratory during this period were collated and analysed. Malaria diagnosis was by microscopy of thick and thin blood films. Date of testing, age, gender and smear results were collected for all malaria positive patients throughout, area of residence from 2002 (District 2002–2007, District and Thana (i.e. subdistrict) 2008–2011), and all of these from 2008 onwards for smear negative patients. In 2006–2011, additional data were collected from patients with malaria and their relatives to determine whether patients had travelled to another Thana in the 3 weeks before presentation. Admission GCS and outcome were also recorded during this period. Many of the malaria slide positive patients were enrolled in a series of clinical studies of severe malaria and a detailed clinical description will be presented elsewhere. Data on population density were taken from the 2001 national census and data on age distribution from the 2004 Sample Vital Registration Survey. Rainfall data for Chittagong were provided by the Bangladesh Meteorological Department, Government of Bangladesh.
In total, there were 22,785 inpatients screened for malaria at CMCH between January 1999 and December 2011. Of these, 2,394 (11%) were positive, 2295/2,394 (96%) with P. falciparum (mean of 177 cases per year), and 93/2,394 (4%) P. vivax. One patient (1/2,384 (0.04%)) had Plasmodium malariae. The median (IQR) age of those who were parasite negative was 25 (15–45) years and those with P. falciparum 26 (18–40) years, p = 0.51. Of those with P. falciparum, 67% were male whereas 59% of parasite negative patients were male (p = 0.002). For 251 unselected patients with P. falciparum between 2008 and 2011, admission Glasgow Coma Scale and outcome were recorded. GCS was <11 in 103/251 (41%) and 44/251 (18%) died.
Number screened, P. falciparum and P. vivax positive cases by District of residence from 2008-2011
% of screens positive
Other (Chittagong Division)
Other (other Divisions)
Travel to another Thana within the 3 weeks preceding admission
Did not travel
Cox's Bazar District
Chittagong Hill Tracts
Thana not specified
The present analysis strongly suggests that only a small proportion of severe cases reach tertiary care (0.2-1.6%), since a mean of 177 malaria patients per year were admitted to CMCH, the only tertiary care facility in the area, whereas the estimated total numbers of severe cases nationally is around 11,000-80,000 per year of which 80% reside in the CHT. One of the explanations could be the financial cost of hospitalization, which is high in proportion to the average income in Bangladesh and can thus be a strong disincentive against admission of less severe patients. Many of the less severe cases we probably treated in peripheral Thana or District hospitals and many cases of severe malaria probably remained untreated in the community. Of the patients admitted to CMCH, 96% had P. falciparum and 4% of patients had P. vivax, whereas mortality was only associated with P. falciparum. Previous studies in uncomplicated malaria in this region show that 70% of malaria is caused by P. falciparum and 30% by P. vivax[1, 5, 8], which emphasizes the benign nature of P. vivax infections in this region. Malaria infection was commonest in young adult males in agreement with previous data from the south of Chittagong Division. This may be related to greater occupational exposure of this group to forest malaria. As the breadwinners, it could be postulated that they are also the family member most likely to be supported to attend a distant hospital for potentially expensive treatment, hence their over-representation in those screened for malaria.
The number of hospitalized P. falciparum cases at CMCH decreased since 2007, despite an increase in the number of patients screened. This decrease was particularly dramatic from 2008–2010. During this period, there have been a number of changes in malaria programmes in the community and a greater than five-fold increase in funding for malaria control[3, 10]. A large increase in the numbers of patients who receive early antimalarial treatment has occurred in the feeder hospitals and clinics referring to CMCH. In particular there has been a doubling of ACT usage from 2007 to 2008[3, 10] and an increase in the availability of parenteral antimalarials. In addition, a new large-scale programme of free distribution of insecticide-treated bednets[3, 10] and introduction of rapid diagnostic tests in the community began in 2008[3, 10]. The present study adds to the evidence that these strategies are having a significant impact. However, potential pockets of high transmission, which are mostly in remote areas may not have been sufficiently covered by this study. Over the past two years there have been initiatives aiming at increased availability of early treatment in more remote areas, including early intravenous therapy in the District hospitals, and as a result it is possible a smaller proportion of cases are being referred to tertiary hospitals.
There was a strong and consistent seasonal pattern of P. falciparum incidence, with a large peak between May and September each year largely coinciding with the maximum rainfall during the monsoon season (June-August). This finding is in contrast with the pattern reported in two earlier reports[3, 6] describing one transmission peak in March-May and one in September-November, with June-August being described as ‘off-peak months’. However, in both these publications no monthly incidence data were presented. For the incidence of P. vivax an additional peak was observed in the months from February to March, before arrival of the rains and transmission of P. falciparum, which uses the same vector system. The same seasonality has been described in vivax malaria in Hooghly District in West Bengal in India, and suggests that these are long latency relapse cases of vivax malaria.
By far the majority of individuals screened for malaria were from the south of Chittagong Division with relatively few from the CHT. All the malaria positive cases were from the south of Chittagong Division in the five endemic Districts: Chittagong, Cox’s Bazar, Kagrachari, Rangamati and Bandarban. Over 80% of cases in Bangladesh are thought to be resident in the CHT[7–9], although in this study only 12% of those referred to CMCH lived there. This is despite it being the main referral hospital for those needing more advanced care and local policy being to refer the sickest cases from all other government hospitals in the area to CMCH.
As expected from existing epidemiological data, the probability of having malaria was highest in screened patients coming from the CHT, particularly the southern part: Lama and Alikadam Thana in Bandarban District but also adjacent Lohagara in Chittagong District. The high rate in Lohagara was mainly caused by an apparent focal epidemic of P. falciparum in 2010.
Population density in the CHT is much lower than elsewhere in Chittagong Division. The most densely inhabited areas are Chittagong City and Cox’s Bazar and their surroundings and both these areas had very few malaria cases. The highest malaria positivity rates per population density in this study were mostly in those from areas of low population density in a band from north to south through the centre of Chittagong Division. These were Fatikchari and Rangonia in Chittagong District, Kawkhali and Rangamati Sadar in Rangamati District and Bandardan Sadar, Lama, Alikadam, and Thanchi Thana in Bandarban District plus Chakaria in Cox’s Bazar District. The high rates in Fatikchari, Rangonia and Chakaria were a particular surprise as these had not been previously identified as high risk areas, although they are near to the forest fringe. Few of the affected individuals in these three areas had visited the adjacent CHT. Even though very few cases of malaria seen at CMCH lived in the CHT, this study indicated almost three times this number, over a third of the total, are likely to have become infected there. Thus the CHT are an important source of malaria both for residents and travelers, although an important proportion of malaria transmission is outside this area, as has also been described in previous studies. Albeit lower transmission outside the CHT, the much larger population in this area contributes significantly to the malaria case load. In this study two thirds of cases had not visited the CHT during the time in which they became infected. Malaria control efforts to date have been particularly focused on the CHT but these data suggest a broader area should be targeted.
There was a limited number of cases from Khagrachari District, the northern third of the CHT, previously found to be the area with the highest transmission in Bangladesh. The small District hospital in Khagrachari town is similar to those in Bandarban and Rangamati and lacks facilities for mechanical ventilation or renal dialysis, which are often needed for patients with severe falciparum malaria. The long travel time to Chittagong might discourage families and physicians from referral to CMCH.
Another underrepresented area known to be highly malarious was Rangamati District, particularly in the east near the border with India, although this area is also an endemic zone with relatively high transmission. There are a number of possible reasons for this. A previous study showed that there is a strong preference among indigenous people in this area for seeking treatment from alternative practitioners in the first instance, although this may be different for the severely ill. Transport from this area to Chittagong is also difficult. Between much of this area and Chittagong city is a large man-made lake, Kaptai Lake, and this can only be crossed by a long journey by boat. Road links to this area are poor, particularly in the wet (malaria) season, and from many areas the travel is long and arduous. These difficult travel conditions might encourage people to seek treatment locally. However, patients from other remote areas with similar difficulties during the wet season did reach CMCH.
Although there are many pharmacies and health centres in the CHT, few of these can provide intravenous treatment and are very limited in their ability to provide more extended supportive care. There are larger and better equipped District hospitals in Khagrachari, Rangamati and Bandarban towns, but these cannot offer mechanical ventilation or renal dialysis, for which referral to a tertiary center is necessary. The dearth of referrals from the CHT to CMCH thus indicates there is likely to be a large burden of patients receiving suboptimal medical treatment in the periphery, and the perceived and real risks of long transportation times to a tertiary treatment centre are likely part of the explanation. For very remote areas in the wet season, it may be that the risk of transport is just too high and the emphasis therefore has to be on improving care locally as much as possible. One recent example has been the introduction of pre-referral treatment with rectal artesunate. This has the advantage that patients begin effective treatment earlier and could potentially ‘buy time’ to allow them to transfer more safely to a better equipped facility. Expanding the availability of effective early antimalarial treatment in general, as has been occurring over the past few years, will also mean fewer patients progressing to severe disease.
Although overall numbers were large, this study had several limitations. All data were from a single tertiary referral hospital. Data were only collected on those patients who had a malaria test by the on-site malaria diagnostic laboratory. There are several private laboratories in Chittagong who also provide malaria tests, although they charge a fee for this service. A small proportion of patients still undergo testing by these private laboratories although the vast majority of these are retested by the hospital laboratory. The study relies on the assumption that the quality of malaria diagnosis did not change significantly from 1999–2011. This is likely to be the case, as the same highly experienced staff were employed throughout and used the same techniques. It does, however also rely on the medical staff referring the same group of patients for testing during this period but data on this were not collected. Numbers of cases from the CHT and total numbers of P. vivax were small. Conclusions regarding P. vivax epidemiology are thus limited in their scope.
Since it has been reported in the most recent government report that in 2008 3.8% of P. falciparum cases in Bangladesh occurred in Chittagong District, and we found that, in 2008, 130/165 CMCH admitted severe malaria cases were from that area, the total national number of severe malaria cases in Bangladesh was at least 130/0.038 = 3460. This figure ignores any patients with severe malaria admitted to the many other hospitals in Chittagong District, as well as those that did not reach healthcare and the actual total is thus likely to be much larger. Official data report a total number of 3591 severe cases for the whole country from mid 2008 to mid 2009, which is thus a severe underestimation and there is a clear need for more accurate and complete reporting. Current systems for collating this data are incomplete and many confirmed cases are missed from the official totals[1–4]. Of particular interest would be the trends in numbers of cases, severe malaria and malaria deaths in the CHT which is essential information to assess the efficacy of malaria control measures as well as for the allocation of resources for patient care.
The lack of epidemiological data on severe and fatal malaria in Bangladesh makes it difficult to plan allocation of healthcare provision to achieve maximum impact on mortality with limited resources. This study demonstrates that a very small proportion of severe malaria cases receive essential high-level supportive care. Patients from the highest transmission zone, the CHT, are particularly underrepresented. These patients could signify an important hidden group with potentially preventable mortality. Despite the recent reductions in malaria incidence and mortality, optimizing care for those developing clinical disease and especially severe malaria remains a priority. Investment in improving early treatment and simple supportive care for severe malaria at peripheral sites should be prioritized together with streamlining referral pathways to higher level care facilities.
The authors would like to thank Mr Sumon Sharma, Dr Tapan Seal and Dr Romal Chowdhury and for their assistance with data entry without which this study would not have been possible. In addition, Begum Jinnatun Nessa for kindly providing rainfall data from the Bangladesh Meteorological Department of the Government of Bangladesh.
Mahidol-Oxford Tropical Medicine Research Unit is funded by the Wellcome Trust of Great Britain.
- Maude RJ, Dondorp AM, Faiz MA, Yunus EB, Samad R, Hossain A, Rahman MR: Malaria in southeast Bangladesh: a descriptive study. Bangladesh Med Res Counc Bull. 2008, 34: 87-89.PubMedGoogle Scholar
- World Health Organization: World malaria report: Bangladesh. 2008,http://www.who.int/malaria/publications/country-profiles/2008/mal2008-bangladesh-en.pdf,Google Scholar
- World Health Organization: Country profile world malaria report: Bangladesh. 2009,http://www.who.int/malaria/publications/country-profiles/2009/mal2009_bangladesh_0012.pdf,Google Scholar
- Malaria and Parasitic Disease Control Unit, Directorate General of Health Services: Strategic Plan for Malaria Control Programme Bangladesh. 2008,http://www.nmcp.info/images/stories/documents/publications/Strategic%20Plan%202008-2015.pdf, –2015,Google Scholar
- World Health Organization: Country profile world malaria report: Bangladesh. 2010,http://www.who.int/malaria/publications/country-profiles/profile_bgd_en.pdf,Google Scholar
- Faiz MA, Yunus EB, Rahman MR, Hossain MA, Pang LW, Rahman ME, Bhuiyan SN: Failure of national guidelines to diagnose uncomplicated malaria in Bangladesh. Am J Trop Med Hyg. 2002, 67: 396-399.PubMedGoogle Scholar
- Malaria and Parasitic Disease Control Unit: Annual Report. 2008, Bangladesh: Directorate General of Health Services,http://www.nmcp.info/images/stories/documents/publications/Annual_Report_08_09.pdf, July to May 2009. GFATM R-6 malaria Component, Bangladesh PR-GoB,Google Scholar
- World Health Organization Regional Office for South-East Asia: Malaria situation in Bangladesh. 2006,http://www.searo.who.int/LinkFiles/Malaria_in_the_SEAR_BAN_mal06i.pdf,Google Scholar
- Haque U, Ahmed SM, Hossain S, Huda M, Hossain A, Alam MS, Mondal D, Khan WA, Khalequzzaman M, Haque R: Malaria prevalence in endemic districts of Bangladesh. PLoS One. 2009, 4: e6737-10.1371/journal.pone.0006737.PubMed CentralView ArticlePubMedGoogle Scholar
- World Health Organization Regional Office for South-East Asia: Malaria situation in SEAR countries. 2010, Bangladesh,http://www.searo.who.int/EN/section10/section21/section340_4015.htm,Google Scholar
- World Health Organization: Guidelines for the treatment of malaria. 2010,http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf, 2,Google Scholar
- Malaria and Parasitic Disease Control Unit: The Diagnosis and Management of Severe Malaria Learner’s Guide. 2010, Bangladesh: Directorate General of Health Services,http://www.nmcp.info/documents/training/2_EDPT_SM.pdf,Google Scholar
- Bangladesh Bureau of Statistics: Area, Population and Literacy Rate by Upazila/Thana-2001.http://www.bbs.gov.bd/dataindex/census/ce_uzila.pdf,
- Bangladesh Bureau of Statistics: Bangladesh data sheet. 2010,http://www.bbs.gov.bd/dataindex/datasheet.xls,Google Scholar
- Haque U, Magalhaes RJS, Reid HL, Clements ACA, Ahmed SM, Islam A, Yamamoto T, Haque R, Glass GE: Spatial prediction of malaria prevalence in an endemic area of Bangladesh. Malar J. 2010, 9: 120-10.1186/1475-2875-9-120.PubMed CentralView ArticlePubMedGoogle Scholar
- Ahmed SM: Different health and health-seeking behaviours: ethnic minorities of the Chittagong Hill Tracts. Bangladesh. Asia Pacif J Public Health. 2001, 13: 100-10.1177/101053950101300208.View ArticleGoogle Scholar
- Iyengar MOT: Seasonal incidence or tertian, subtertian and quartan infections. Ind J Med Res. 1932, 20: 303-Google Scholar
- Roll Back Malaria: Bangladesh country profile. 2005,http://www.rollbackmalaria.org/wmr2005/profiles/bangladesh.pdf,Google Scholar
- Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, Baiden F, Yunus EB, Binka F, Clerk C, Folb P, Hassan R, Hossain MA, Kimbute O, Kitua A, Krishna S, Makasi C, Mensah N, Mrango Z, Olliaro P, Peto R, Peto TJ, Rahman MR, Ribeiro I, Samad R, White NJ, Study 13 Research Group: Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet. 2009, 373: 557-566. 10.1016/S0140-6736(08)61734-1.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.